Related Experiment Videos

Compliance with therapy in children with respiratory diseases

M H Schöni1, E Horak, W H Nikolaizik

  • 1Alpine Children's Hospital Davos, Davos Platz, Switzerland.

Insights

Patient adherence to respiratory medication is low, with only 47.6% compliance observed. Inadequate theophylline dosages, often due to physician prescribing errors, further compromise treatment effectiveness in children and adolescents.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacology

Background:

  • Asthma and other respiratory diseases are common in children and adolescents.
  • Effective management relies on consistent adherence to prescribed medical treatments.
  • Assessing true medication compliance in pediatric populations presents significant challenges.

Purpose of the Study:

  • To evaluate medical treatment compliance in pediatric patients with respiratory diseases.
  • To compare the effectiveness of different assessment methods for compliance.
  • To identify factors influencing medication adherence in this demographic.

Main Methods:

  • Utilized a double-blinded, covert recording of air compressor use for nebulization.
  • Determined serum theophylline levels as a biochemical marker of compliance.
  • Conducted an open, randomized trial for theophylline dosage assessment.

Main Results:

  • Covert monitoring revealed an overall medication compliance rate of 47.6%.
  • In the theophylline trial, 56%-71% of patients had sub-therapeutic serum levels (10-20 mg/l).
  • Physicians prescribed doses below recommended levels in 72% of cases, contributing to low serum concentrations.

Conclusions:

  • Medication compliance is multifactorial, influenced by patient adherence.
  • Drug efficacy and physician prescribing practices significantly impact treatment outcomes.
  • Improved physician education on appropriate dosing is crucial for pediatric respiratory care.

Related Concept Videos